Last reviewed · How we verify
NCT05853822
FirmTech User Research Trial
trial testing FirmTech Tech Ring in Erectile Function in 51 participants. Completed in 20 October 2023.
20 October 2023
Quick facts
| Lead sponsor | Reproductive Medicine Associates of New Jersey |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 51 |
| Start date | 2 May 2023 |
| Primary completion | 20 October 2023 |
| Estimated completion | 20 October 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- FirmTech Tech Ring
- Giddy Penile Constriction Ring
Conditions studied
- Erectile Function — all drugs for Erectile Function →
Sponsor
Reproductive Medicine Associates of New Jersey — full company profile →
Who can join
Adults 18 to 70, male only, with Erectile Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to see whether a home-use penile constriction device, Firmtech Tech Ring, can be determined to be superior to the Giddy device through evaluation of Leikert scale scores to assess ease of use and participant comfort and satisfaction with erectile quality with these devices. The primary outcome will be the satisfaction with use of the device as assessed through the Leikert scores. The other outcomes will be secondary.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Penile constriction devices: a randomized survey study to compare preferences between two medical-grade devices.
Rendon DO, Saffati G, Whitehead C, Zuckerman C, et al · · 2025 · PMID 39545359 · DOI 10.1093/jsxmed/qdae151
Verify or expand the search:
- PubMed search for NCT05853822
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Erectile Function
Currently open trials in the same condition.
- NCT06822036 — EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP · NA · recruiting
- NCT06717711 — Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genit · Phase 3 · recruiting
Other Reproductive Medicine Associates of New Jersey trials
Trials by the same sponsor.
- NCT06074055 — PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer · NA · terminated
- NCT05397912 — Uterine Elastography: a Potential Predictor of Embryo Transfer Success · completed
- NCT04852029 — Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Ferti · NA · terminated
- NCT04693806 — The Effect of Embryo Culture Under a Continuous CO2 Setting Versus a Sequential CO2 Setting · NA · completed
- NCT04496284 — Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05853822 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Reproductive Medicine Associates of New Jersey
- Last refreshed: 7 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05853822.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing